Quantcast
Channel: Genetherapy » a-from-the
Browsing all 38 articles
Browse latest View live

GenomePooling™ method is sensitive and accurate

Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling method is...

View Article



Population Genetics validates GenomePooling™ for cancer

Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling method is...

View Article

NewLink Genetics Corporation Reports Second Quarter 2012 Financial Results

AMES, Iowa, Aug. 14, 2012 (GLOBE NEWSWIRE) — NewLink Genetics Corporation (NLNK), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today reported...

View Article

Melbourne researchers develop genetic test to predict risk of autism spectrum...

A team of Australian researchers, led by University of Melbourne has developed a genetic test that is able to predict the risk of developing Autism Spectrum Disorder, ASD. Lead researcher Professor...

View Article

Both genetics and environment influence peoples' choice of friends

London, November 1 (ANI): A team led by University of Colorado Boulder researchers has found that genetic similarities may help to explain why human birds of a feather flock together, but the full...

View Article


First commercial gene therapy approved for Europe

A gene-therapy medicine has been given commercial approval in Europe for the first time. The treatment, Glybera, is designed to help those suffering from lipoprotein lipase deficiency — an inherited...

View Article

Inflammation may be a cause of plaque buildup in heart vessels

ScienceDaily (Dec. 2, 2012) Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists — including researchers at the...

View Article

Interim results from Seattle Genetics’ ASG-5ME phase I trial on metastatic PDA

Seattle Genetics, Inc. (Nasdaq: SGEN) today presented interim results from a phase I clinical trial evaluating ASG-5ME for the treatment of metastatic pancreatic ductal adenocarcinoma (PDA) at the...

View Article


Data From SGEN on Cancer Candidate

Seattle Genetics, Inc. (SGEN) recently presented interim results from a phase I study which is evaluating ASG-5ME for the treatment of metastatic pancreatic ductal adenocarcinoma (:PDA). Seattle...

View Article


ReNeuron Group edges further in stem cell therapy research for stroke patients

LONDON (ShareCast) – ReNeuron Group received the green light to complete the final stages of first phase safety testing of its ReN001 stem cell therapy for disabled stroke patients in Scotland, the...

View Article

International Stem Cell Corporation to Present at American Society of Gene...

CARLSBAD, CA–(Marketwired – May 1, 2013) – International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell based...

View Article

Critical Outcome Technologies Inc.: Promising Advance for Many Common Cancers

LONDON, ONTARIO–(Marketwired – June 11, 2013) -Critical Outcome Technologies Inc. (TSX VENTURE:COT) (“COTI” or the “Corporation”) announces positive results from experiments carried out with its lead...

View Article

Urge to start smoking could be genetic, study says

Smokers are more likely to have children who also smoke, even if they quit before their child was born, MedPage Today reported. In a study published in the journal Pediatrics, researchers discovered...

View Article


Data on Cytori's Cell Therapy

Cytori Therapeutics, Inc. (CYTX) provided preliminary data from a study evaluating a potential treatment for scleroderma based on the companys cell therapy. The investigator-funded, open-label, pilot...

View Article

Pipeline Update at Alnylam – Analyst Blog

Alnylam Pharmaceuticals Inc. ( ALNY ) provided an update on its pipeline and its goals for the coming years. The company has progressed well with its ‘Alnylam 5×15′ program so far, and expects six to...

View Article


New Study Unleashes Potential Revolution in Stem Cell Research

In what is seen as a new era in stem cell biology, scientists have easily changed a differentiated cell back to an embryonic-like state by altering its environment. The new method does not involve any...

View Article

International Stem Cell Corporation Announces Positive Interim Data From...

International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today announced positive data from the first interim...

View Article


Menopausal hormone therapy may lower risk of B-cell non-Hodgkin lymphoma

Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link...

View Article

Hormone therapy linked to lower non-Hodgkin lymphoma risk

Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link...

View Article

Cochlear Implant Also Uses Gene Therapy to Improve Hearing

The electrodes in a cochlear implant can be used to direct gene therapy and regrow neurons. Growth factor: The cochlear nerve regenerates after gene therapy (top) versus the untreated cochlea from the...

View Article
Browsing all 38 articles
Browse latest View live




Latest Images